Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Koeppen

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2012
GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivoJeffrey J Wallin, Jane Guan, Wei Wei Prior, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2009
Application of COLD-PCR for improved detection of KRAS mutations in clinical samplesZhuang Zuo, Su S Chen, Pranil K Chandra, et al.
Cancer|August 13, 2009
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutationWeina Chen, Sergej Konoplev, L Jeffrey Medeiros, et al.
The Journal of Cell Biology|December 13, 2017
SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancerManuel Viotti, Catherine Wilson, Mark McCleland, et al.
Cancer Research|August 16, 2014
AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugsCatherine Wilson, Xiaofen Ye, Thinh Pham, et al.
Cancer|July 29, 2009
Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosisSergej Konoplev, Xuelin Huang, Harry A Drabkin, et al.
The Journal of Pathology|April 1, 2009
Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinomaLaura A Strickland, Jed Ross, Simon Williams, et al.
Plos One|April 7, 2015
MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomasKatja Schmitz, Hartmut Koeppen, Elke Binot, et al.
Pigment Cell & Melanoma Research|November 21, 2017
Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenibMatthew J Wongchenko, Antoni Ribas, Brigitte Dréno, et al.
Nature Cell Biology|May 30, 2017
Stem cell plasticity enables hair regeneration following Lgr5<sup>+</sup> cell lossJoerg D Hoeck, Brian Biehs, Antonina V Kurtova, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2012
GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivoJeffrey J Wallin, Jane Guan, Wei Wei Prior, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2009
Application of COLD-PCR for improved detection of KRAS mutations in clinical samplesZhuang Zuo, Su S Chen, Pranil K Chandra, et al.
Cancer|August 13, 2009
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutationWeina Chen, Sergej Konoplev, L Jeffrey Medeiros, et al.
The Journal of Cell Biology|December 13, 2017
SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancerManuel Viotti, Catherine Wilson, Mark McCleland, et al.
Cancer Research|August 16, 2014
AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugsCatherine Wilson, Xiaofen Ye, Thinh Pham, et al.
Cancer|July 29, 2009
Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosisSergej Konoplev, Xuelin Huang, Harry A Drabkin, et al.
The Journal of Pathology|April 1, 2009
Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinomaLaura A Strickland, Jed Ross, Simon Williams, et al.
Plos One|April 7, 2015
MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomasKatja Schmitz, Hartmut Koeppen, Elke Binot, et al.
Pigment Cell & Melanoma Research|November 21, 2017
Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenibMatthew J Wongchenko, Antoni Ribas, Brigitte Dréno, et al.
Nature Cell Biology|May 30, 2017
Stem cell plasticity enables hair regeneration following Lgr5<sup>+</sup> cell lossJoerg D Hoeck, Brian Biehs, Antonina V Kurtova, et al.
Pageof 15